| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |